UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025316 |
|---|---|
| Receipt number | R000029116 |
| Scientific Title | Examination of relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin-angiotensin system |
| Date of disclosure of the study information | 2016/12/18 |
| Last modified on | 2024/07/03 08:48:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Examination of relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin-angiotensin system
Acronym
Examination of relationship between progression of CKD of CAKUT and RAS
Scientific Title
Examination of relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin-angiotensin system
Scientific Title:Acronym
Examination of relationship between progression of CKD of CAKUT and RAS
Region
| Japan |
Condition
Condition
Congenital Anomalies of Kidney and Urinary Tract
Classification by specialty
| Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investidate relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin angiotensin system
Basic objectives2
Others
Basic objectives -Others
To investidate relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin angiotensin system in serum and urine
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Significant relationship between progression of chronic kidney disease of congenital anomalies of kidney and urinary tract and renin angiotensin system
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | days-old | <= |
Age-upper limit
| 15 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Congenital anomalies of kidney and urinary tract
Key exclusion criteria
do not have congenital anomalies of kidney and urinary tract
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Shingo |
| Middle name | |
| Last name | Ishimori |
Organization
Kobe University Graduate school of Medicine
Division name
Department of pediatrics
Zip code
650-0017
Address
7-5-1 Kusunokicho, Kobe city, Hyogo, Japan
TEL
078-382-6090
shingo-i0324os@live.jp
Public contact
Name of contact person
| 1st name | Shingo |
| Middle name | |
| Last name | Ishimori |
Organization
Kobe University Graduate school of Medicine
Division name
Department of pediatrics
Zip code
650-0017
Address
7-5-1 Kusunokicho, Kobe city, Hyogo, Japan
TEL
078-382-6090
Homepage URL
shingo-i0324os@live.jp
Sponsor or person
Institute
Kobe University Graduate school of Medicine
Institute
Department
Personal name
Funding Source
Organization
Kobe University Graduate school of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Board of Takatsuki General Hospital
Address
1-3-13 Kosobe-cho, Takatsuki city, Osaka, Japan
Tel
0726813801
shingo-i0324os@live.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2016 | Year | 12 | Month | 18 | Day |
Date of IRB
| 2022 | Year | 10 | Month | 06 | Day |
Anticipated trial start date
| 2016 | Year | 12 | Month | 18 | Day |
Last follow-up date
| 2026 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The value of various examination in renal immunohistopathological staining, abdominal ultrasound, serum and urine
Management information
Registered date
| 2016 | Year | 12 | Month | 18 | Day |
Last modified on
| 2024 | Year | 07 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029116
